Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Newland

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Immunotherapy|October 3, 2017
Fostamatinib for persistent/chronic adult immune thrombocytopeniaAdrian Newland, Eun-Ju Lee, Vickie McDonald, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
The Health Technology Assessment of companion diagnostics: experience of NICESarah K Byron, Nick Crabb, Elisabeth George, et al.
European Journal of Haematology|May 21, 2016
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysisIndraraj Umesh Doobaree, Raghava Nandigam, Dimitri Bennett, et al.
Cytometry. Part B, Clinical Cytometry|December 25, 2002
Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole bloodMarion Macey, Desmond McCarthy, Urooj Azam, et al.
Hematology (Amsterdam, Netherlands)|October 4, 2021
Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study)Vickie McDonald, Adrian Newland, Mervyn Morgan, et al.
British Journal of Haematology|November 6, 2015
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 studyAdrian Newland, Bertrand Godeau, Victor Priego, et al.
Clinical Chemistry|May 25, 2002
Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology systemMarion Macey, Urooj Azam, Desmond McCarthy, et al.
Blood Reviews|June 28, 2024
Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatmentJohn W Semple, Alexandra Schifferli, Nichola Cooper, et al.
European Journal of Haematology|February 14, 2019
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP RegistryIndraraj Umesh Doobaree, Adrian Newland, Vickie McDonald, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Immunotherapy|October 3, 2017
Fostamatinib for persistent/chronic adult immune thrombocytopeniaAdrian Newland, Eun-Ju Lee, Vickie McDonald, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
The Health Technology Assessment of companion diagnostics: experience of NICESarah K Byron, Nick Crabb, Elisabeth George, et al.
European Journal of Haematology|May 21, 2016
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysisIndraraj Umesh Doobaree, Raghava Nandigam, Dimitri Bennett, et al.
Cytometry. Part B, Clinical Cytometry|December 25, 2002
Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole bloodMarion Macey, Desmond McCarthy, Urooj Azam, et al.
Hematology (Amsterdam, Netherlands)|October 4, 2021
Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study)Vickie McDonald, Adrian Newland, Mervyn Morgan, et al.
British Journal of Haematology|November 6, 2015
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 studyAdrian Newland, Bertrand Godeau, Victor Priego, et al.
Clinical Chemistry|May 25, 2002
Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology systemMarion Macey, Urooj Azam, Desmond McCarthy, et al.
Blood Reviews|June 28, 2024
Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatmentJohn W Semple, Alexandra Schifferli, Nichola Cooper, et al.
European Journal of Haematology|February 14, 2019
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP RegistryIndraraj Umesh Doobaree, Adrian Newland, Vickie McDonald, et al.
Pageof 5